Atherosclerosis and its clinical complications—coronary artery disease (CAD), myocardial infarction, and stroke—continue to be leading causes of death globally. Despite significant improvements in managing traditional risk factors, current strategies for modulating and monitoring atherosclerosis risk primarily focus on low-density lipoprotein cholesterol (LDL-C) and its therapeutic reduction.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile